Jump Trading’s Larimar Therapeutics LRMR Stock Holding History

Jump Trading’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,479	Closed	-$49K	–	477
2019 Q1	$49K	Buy	+1,479	New	+$75.8K	0.02%	526

Other funds holding LRMR

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jump Trading's LRMR Position: Q2 2019 in Review

Jump Trading sold out of Larimar Therapeutics (LRMR) in Q2 2019, closing a stake of 1,479 shares — an estimated $49K sold.

Jump Trading first reported a position in LRMR in Q1 2019 and held it in 1 quarter. The position peaked at $49K in Q1 2019. 71 funds tracked by Wall St. Rank hold LRMR as of Q2 2019.

Jump Trading reported no remaining Larimar Therapeutics position as of Q2 2019 after selling out during the quarter.
Jump Trading sold 1,479 Larimar Therapeutics shares in Q2 2019, an estimated $49K.
Jump Trading first reported a position in Larimar Therapeutics in Q1 2019 and held it in 1 quarter.
Jump Trading's Larimar Therapeutics position peaked at $49K in Q1 2019.
71 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2019.

Based on Jump Trading's 13F filing for Q2 2019, filed 14 Aug 2019.